ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
58 hedge funds and large institutions have $11.5M invested in Oncternal Therapeutics, Inc. Common Stock in 2013 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 16 increasing their positions, 24 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
46% less call options, than puts
Call options by funds: $266K | Put options by funds: $497K
Holders
58
Holding in Top 10
–
Calls
$266K
Puts
$497K
Top Buyers
| 1 | +$625K | |
| 2 | +$555K | |
| 3 | +$130K | |
| 4 |
TCIM
TIAA CREF Investment Management
New York
|
+$104K |
| 5 |
WMSA
Weiss Multi-Strategy Advisers
New York
|
+$100K |
Top Sellers
| 1 | -$1.19M | |
| 2 | -$1.01M | |
| 3 | -$602K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$507K |
| 5 |
D.E. Shaw & Co
New York
|
-$499K |